Development
Moderna, Inc.
MRNA
$25.35
-$1.77-6.53%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.71B | -3.47B | 1.21B | 4.78B | 8.36B |
| Total Depreciation and Amortization | 621.00M | 499.00M | 363.00M | 347.00M | 348.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.11B | 1.12B | -475.00M | -428.00M | -274.00M |
| Change in Net Operating Assets | -139.00M | -235.00M | -1.32B | -3.71B | -3.46B |
| Cash from Operations | -3.12B | -2.08B | -226.00M | 993.00M | 4.98B |
| Capital Expenditure | -707.00M | -579.00M | -528.00M | -381.00M | -400.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -85.00M | -85.00M | -85.00M | -85.00M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.00B | 4.36B | 4.47B | 1.22B | -4.78B |
| Cash from Investing | 4.21B | 3.70B | 3.85B | 756.00M | -5.18B |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -270.00M | -207.00M | -188.00M | -178.00M | -184.00M |
| Issuance of Common Stock | 47.00M | 57.00M | 61.00M | 62.00M | 65.00M |
| Repurchase of Common Stock | -1.15B | -1.56B | -2.56B | -3.23B | -3.33B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.38B | -1.71B | -2.69B | -3.35B | -3.45B |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -289.00M | -88.00M | 937.00M | -1.60B | -3.64B |